Aesthetics Biomedical is a U.S.-based aesthetic technology company dedicated to advancing safer, smarter, and more precise aesthetic treatments. The company partners with forward-thinking providers to deliver clinically driven platforms that prioritize outcomes, confidence and patient safety. The portfolio includes innovative energy-based devices designed to elevate care through precision and personalization, including UltraVision RF Microneedling with integrated ultrasound visualization, Reverso RF resurfacing, EliteNS monopolar RF therapy, CryoTouchMD carboxy delivery, and SoME autologous skincare solutions. Each platform is developed with a focus on intelligent energy delivery, thoughtful engineering and real-world clinical application. The mission is to support providers with technology that removes guesswork, enhances treatment planning, and delivers consistent, high-quality results. By combining advanced engineering, education, and strategic partnerships, Aesthetics Biomedical helps practices stay ahead of the evolving aesthetics landscape while maintaining the highest standards of care.